社区药剂师对儿童急性腹的治疗模式和咨询:基于模拟的横截面研究
1Department of Pharmacy Practice, College of Pharmacy, Qassim University, Saudi Arabia.
The journal of medicine access
|June 5, 2024
概括
在也门,社区药剂师在儿童腹管理方面存在差距. 他们在模拟中表现不佳,评估,咨询和口服补水溶液建议不足.
科学领域:
- 药房实践的做法 在药房实践.
- 儿科卫生保健 儿科卫生保健
- 全球卫生健康 全球卫生健康
背景情况:
- 腹是全球儿童死亡的主要原因,特别是在资源有限和受冲突影响的地区,如也门.
- 五岁以下儿童的急性腹在全球范围内仍然是一个重大的公共卫生问题.
研究的目的:
- 评估社区药剂师对也门儿童急性腹的治疗模式.
- 评估药剂师提供关于儿科腹管理的咨询质量.
主要方法:
- 一项基于模拟的横截面研究在也门的萨那市进行.
- 社区药剂师使用问卷和模拟客户方法进行评估.
- 评估重点是病例评估 (年龄,腹频率,发烧,血液/粘液),建议和咨询.
主要成果:
- 只有3%的药剂师在模拟的客户互动中使用了所有五个关键指标,而在问卷中则为43%.
- 口服补水液 (ORS) 建议在模拟中不足 (6%单独,47%与其他药物一起使用),40%仅分发抗生素.
- 咨询质量差异很大,89%的人在问卷中报告了充分的解释,而在模拟中只有36%.
结论:
- 在也门,社区药剂师在模拟场景中对患有急性腹的儿童进行评估不足.
- 药剂师提供了不充分的饮食建议和不充分的口服补水液 (ORS) 建议.
- 药剂师自我报告的做法与他们在模拟患者接触中的实际表现之间存在显著的差异.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
117
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
117
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
205
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
205
Drugs for Treatment of Diarrhea-Predominant IBS
159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
191
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
191
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126


